Psoriatic Arthritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Psoriatic Arthritis clinical trial market research report provides an overview and top-line data relating to the clinical trials on Psoriatic Arthritis. The report includes an overview of trials count and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number of ongoing trials).
Psoriatic Arthritis Clinical Trials Market Distribution by Regions and Countries
The top regions in the Psoriatic Arthritis clinical trials market are Europe, Asia Pacific, North America, the Middle East and Africa, and South and Central America. Most of the clinical trials were conducted in Europe.
In a country-wise analysis, as of August 2022, the US has the highest number of Psoriatic Arthritis clinical trials, followed by Germany, the UK, Spain, Russia, Poland, and Belgium. Belgium has the highest average patient enrollment in Psoriatic Arthritis clinical trials.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Germany has the highest proportion of Psoriatic Arthritis to Musculoskeletal Disorders clinical trials as of August 2022.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of Psoriatic Arthritis to Musculoskeletal Disorders clinical trials as of August 2022.
Psoriatic Arthritis Clinical Trials Market Analysis, By Regions
For more regional insights on Psoriatic Arthritis clinical trials market , download a free report sample
Psoriatic Arthritis Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the Psoriatic Arthritis clinical trials market are the company, institution, and government. Out of them, the company segment dominates the market.
Psoriatic Arthritis Clinical Trials Market Analysis, by Sponsor Types
To know more about key sponsor types in Psoriatic Arthritis clinical trials market , download a free report sample
Competitive Landscape
The leading companies in the Psoriatic Arthritis clinical trials market are AbbVie Inc, Johnson & Johnson, Pfizer Inc, Novartis AG, Amgen Inc, Bristol-Myers Squibb Co, UCB SA, ICON Plc, Merck & Co Inc, and C. H. Boehringer Sohn AG & Co KG. AbbVie Inc sponsored the highest number of psoriatic arthritis clinical trials.
Psoriatic Arthritis Clinical Trials Market Analysis, by Leading Companies
To know more about leading companies in the Psoriatic Arthritis clinical trials market, download a free report sample
Psoriatic Arthritis Clinical Trials Market Report Overview
Key Regions | Europe, Asia-Pacific, Northern America, Middle East and Africa, and South and Central America |
Key Countries | The US, Germany, the UK, Spain, Russia, Poland, South Korea, Japan, Taiwan, Qatar, and Chile |
Key Sponsor Types | Company, Institution, and Government |
Leading Companies | AbbVie Inc, Johnson & Johnson, Pfizer Inc, Novartis AG, Amgen Inc, Bristol-Myers Squibb Co, UCB SA, ICON Plc, Merck & Co Inc, and C. H. Boehringer Sohn AG & Co KG |
Scope
The report provides:
- A snapshot of the global clinical trials landscape
- Top level data related to the clinical trials by region, country, trial status, trial phase, sponsor type, and end point status
- Reviews of top companies involved and enlists all trials pertaining to the company
- All the unaccomplished trials with the reason for unaccomplishment
- Enrollment trends for the past five years
- Latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Johnson & Johnson
Pfizer Inc
Novartis AG
Amgen Inc
Bristol-Myers Squibb Co
UCB SA
ICON Plc
Merck & Co Inc
C. H. Boehringer Sohn AG & Co KG
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key regions in the Psoriatic Arthritis clinical trials market?
The top regions in the Psoriatic Arthritis clinical trials market are Asia-Pacific, Europe, North America, Middle East and Africa, and South and Central America.
-
What are the key countries in the Psoriatic Arthritis clinical trials market?
The top countries in the Psoriatic Arthritis clinical trials market are the US, Germany, the UK, Spain, Russia, Poland, South Korea, Japan, Taiwan, Qatar, and Chile.
-
What are the key sponsor types in the Psoriatic Arthritis clinical trials market?
Companies, institutions, and government are the key sponsor types in the Psoriatic Arthritis clinical trials market.
-
Which are the leading companies in the Psoriatic Arthritis clinical trials market?
The leading companies in the Psoriatic Arthritis clinical trials market are AbbVie Inc, Johnson & Johnson, Pfizer Inc, Novartis AG, Amgen Inc, Bristol-Myers Squibb Co, UCB SA, ICON Plc, Merck & Co Inc, and C. H. Boehringer Sohn AG & Co KG.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.